Literature DB >> 31006094

M51R and Delta-M51 matrix protein of the vesicular stomatitis virus induce apoptosis in colorectal cancer cells.

Zahra Gray1, Alijan Tabarraei1, Abdolvahab Moradi2, Mohamad R Kalani3,4.   

Abstract

Colorectal cancer (CRC) is the third most common cancer in both men and women. Oncolytic viral-based therapy methods seem to be promising for CRC treatment. Vesicular stomatitis virus (VSV) is considered as a potent candidate in viral therapy for several tumors. VSV particles with mutated matrix (M) protein are capable of initiating cell death cascades while not being harmful to the immune system. In the current study, the effects of the VSV M-protein was investigated on the apoptosis of the colorectal cancer SW480 cell. Wild-type, M51R, and ΔM51 mutants VSV M-protein genes were cloned into the PCDNA3.1 vector and transfected into the SW480 cells. The results of the MTT assay, Western blotting, and Caspase 3, 8, and 9 measurement, illustrated that both wild and M51R mutant M-proteins can destroy the SW480 colorectal cancer cells. DAPI/TUNEL double-staining reconfirmed the apoptotic effects of the M-protein expression. The ΔM51 mutant M-protein is effective likewise M51R, somehow it can be considered as a safer substitution.

Entities:  

Keywords:  Apoptosis; Colon cancer; Oncolytic virus; VSV

Mesh:

Substances:

Year:  2019        PMID: 31006094     DOI: 10.1007/s11033-019-04799-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  45 in total

1.  Oncolytic viruses move forward in clinical trials.

Authors:  Karen Rowan
Journal:  J Natl Cancer Inst       Date:  2010-04-26       Impact factor: 13.506

2.  Characterization of the Interaction between the Matrix Protein of Vesicular Stomatitis Virus and the Immunoproteasome Subunit LMP2.

Authors:  Frauke Beilstein; Linda Obiang; Hélène Raux; Yves Gaudin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.

Authors:  Valérie Janelle; Frédérick Brassard; Pascal Lapierre; Alain Lamarre; Laurent Poliquin
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

4.  Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx.

Authors:  Daniel F Gaddy; Douglas S Lyles
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

5.  The matrix protein of vesicular stomatitis virus binds dynamin for efficient viral assembly.

Authors:  Hélène Raux; Linda Obiang; Nicolas Richard; Francis Harper; Danielle Blondel; Yves Gaudin
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

6.  Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions.

Authors:  S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

7.  IFN-beta-induced alteration of VSV protein phosphorylation in neuronal cells.

Authors:  Paul M D'agostino; Jessica J Amenta; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

8.  Impaired interferon signaling is a common immune defect in human cancer.

Authors:  Rebecca J Critchley-Thorne; Diana L Simons; Ning Yan; Andrea K Miyahira; Frederick M Dirbas; Denise L Johnson; Susan M Swetter; Robert W Carlson; George A Fisher; Albert Koong; Susan Holmes; Peter P Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

9.  Defective translational control facilitates vesicular stomatitis virus oncolysis.

Authors:  Siddharth Balachandran; Glen N Barber
Journal:  Cancer Cell       Date:  2004-01       Impact factor: 31.743

Review 10.  Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.

Authors:  Iris D Nagtegaal; Nikki Knijn; Niek Hugen; Helen C Marshall; Kenichi Sugihara; Tibor Tot; Hideki Ueno; Philip Quirke
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544

View more
  3 in total

1.  Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner.

Authors:  Andreas Linder; Viktoria Bothe; Nicolas Linder; Paul Schwarzlmueller; Frank Dahlström; Christoph Bartenhagen; Martin Dugas; Dharmendra Pandey; Julia Thorn-Seshold; Daniel F R Boehmer; Lars M Koenig; Sebastian Kobold; Max Schnurr; Johannes Raedler; Giulia Spielmann; Hadi Karimzadeh; Andreas Schmidt; Stefan Endres; Simon Rothenfusser
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

2.  NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein.

Authors:  Zoleikha Mamizadeh; Mohamad Reza Kalani; Masoud Parsania; Mohammad Mehdi Soltan Dallal; Abdolvahab Moradi
Journal:  Mol Ther Oncolytics       Date:  2021-11-24       Impact factor: 7.200

Review 3.  Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors.

Authors:  Qingbo Li; Patrick Kwabena Oduro; Rui Guo; Ruiqiao Li; Ling Leng; Xianbin Kong; Qilong Wang; Long Yang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-03       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.